AbCellera Biologics Cash Flow Statement (2020-2026) | ABCL

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M-40.61M-36.93M-51.11M-34.21M-45.62M-34.73M-57.12M-8.95M-43.16M
Depreciation and Depletion (Quarter)
1.10M1.20M1.30M1.40M2.30M2.50M2.74M2.86M3.00M3.10M3.88M3.20M3.40M3.80M2.10M4.40M4.50M4.30M5.14M5.92M
Share-based Compensation (Quarter)
8.47M7.71M9.04M12.29M12.11M11.75M13.32M15.47M16.40M15.86M16.45M17.41M17.78M17.16M15.23M14.79M14.21M13.89M12.90M12.01M
Deferred Taxes (Quarter)
0.13M-4.02M1.25M
Cash from Operations (Quarter)
157.68M-5.93M-16.71M100.22M273.01M-126.79M30.91M-44.06M19.90M-0.11M-19.61M-41.71M-29.97M-28.88M-8.00M-11.55M-32.40M-52.59M-34.74M-33.52M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.69M0.54M0.89M0.98M1.14M1.57M1.57M1.61M1.65M1.67M1.57M1.92M1.51M1.38M1.34M1.27M1.59M1.99M1.80M1.82M
Depreciation & Amortization (CF) (Quarter)
1.10M1.20M1.30M1.40M2.30M2.50M2.74M2.86M3.00M3.10M3.88M3.20M3.40M3.80M2.10M4.40M4.50M4.30M5.14M5.92M
Change in Working Capital
Change in Receivables (Quarter)
-1.73M5.99M3.06M8.75M-1.79M-3.29M19.04M-7.92M32.18M11.23M10.44M18.58M15.86M19.82M20.86M1.13M11.39M3.43M39.67M-13.10M
Change in Account Payables (Quarter)
3.49M-22.91M27.95M0.75M-2.63M-2.80M1.52M-5.78M-10.47M14.40M-4.88M4.88M
Change in Accured Expenses (Quarter)
-4.88M4.75M4.15M6.62M-3.41M-3.95M5.07M5.74M-9.41M
Change in Taxes (Quarter)
-24.21M0.77M16.03M69.97M-17.71M-87.19M-53.67M-12.61M35.50M5.80M1.78M-3.18M-2.77M-2.76M15.36M-4.41M-3.18M-12.20M-10.05M-4.97M
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
36.80M8.57M9.43M14.49M31.32M12.51M12.33M14.98M27.20M20.33M14.43M24.14M20.11M18.52M15.63M10.64M13.37M8.93M9.84M3.83M
Change in Acquisitions & Divestments (Quarter)
18.08M57.29M88.51M272.43M92.39M262.64M160.18M220.10M268.02M306.55M232.84M196.60M201.89M190.03M113.41M83.10M119.54M143.80M
Cash from Investing Activities (Quarter)
-45.63M-269.63M-1.15M-26.37M-27.20M-281.99M-17.06M-149.61M-34.39M-12.79M-24.32M29.91M52.10M3.70M35.70M7.93M-31.81M36.49M75.14M-25.08M
Financing Activities
Other financing activities (Quarter)
1.71M0.90M1.83M0.49M0.33M0.26M0.89M0.46M0.23M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
0.90M1.83M1.94M0.23M0.23M0.35M6.56M5.03M2.12M2.37M3.10M5.90M
Long-Term Debt Repayments (Quarter)
0.11M
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
45.68M17.96M37.53M20.71M22.46M
Misc.
Cash from Financing Activities (Quarter)
-5.08M0.90M1.83M-3.13M1.17M-0.02M0.35M-0.46M0.42M6.63M3.77M2.83M2.65M3.15M4.14M5.97M-3.38M7.37M4.12M7.19M
Exchange Rate Effect (Quarter)
-0.20M-0.22M-0.53M-0.20M-1.21M-8.55M0.36M-0.21M0.80M-1.06M1.07M-0.78M-0.04M0.37M-2.16M0.59M0.76M-0.54M0.29M-0.04M
Change in Cash (Quarter)
106.78M-274.88M-16.55M70.51M245.78M-417.35M14.56M-194.34M-13.27M-7.33M-39.10M-9.75M24.74M-21.67M29.68M2.94M-66.83M-9.28M44.80M-51.45M
Free Cash Flow (Quarter)
120.88M-14.51M-26.14M85.72M241.69M-139.30M18.58M-59.05M-7.30M-20.44M-34.04M-65.85M-50.08M-47.40M-23.63M-22.19M-45.77M-61.52M-44.59M-37.35M
Net Cash Flow (Quarter)
106.97M-274.66M-16.03M70.72M246.99M-408.80M14.20M-194.13M-14.07M-6.26M-40.17M-8.97M24.78M-22.04M31.84M2.35M-67.59M-8.73M44.51M-51.41M